40174 results about "Sodium" patented technology

A method of making sodium zirconium carbonate is described which involves forming a mixture of zirconium oxychloride with soda ash and then heating at a sufficient temperature and for a sufficient time to form the sodium zirconium carbonate. Subsequent washing and filtration steps can further form parts of this process. A novel sodium zirconium carbonate is further described which contains from about 2 wt % to about 5 wt % Na<+>; from about 44 wt % to about 50 wt % ZrO2; from about 12 wt % to about 18 wt % CO3<2->; and from about 32 wt % to about 35 wt % H2O.

The active component of ultrastable Y-type RE molecular sieve is composite modified Y-zeolite containing RE oxide 8-25 wt%, P 0.1-3.0 wt% and sodium oxide 0.3-2.5 wt%, and with degree of crystallization 30-55 % and unit cell parameter 2.455-2.477 nm. It is prepared with Y-zeolite as material and through the steps of exchange with RE and the first roasting to obtain RE-Na Y-zeolite; reaction with RE, reaction with P-containing compound, and the second roasting. The ultrastable Y-type RE molecular sieve is used as the active component of cracking catalyst and has the obvious effect of lowering olefin content in gasoline and the features of resulting in moderate coke yield and high diesel oil yield. The preparation process is simple and high in the utilization of the modifying elements.

A method for treating an oil shale formation comprising dawsonite includes providing heat from one or more heaters to the formation to heat the formation. Hydrocarbon fluids are produced from the formation. At least some dawsonite in the formation is decomposed with the provided heat. A chelating agent is provided to the formation to dissolve at least some dawsonite decomposition products. The dissolved dawsonite decomposition products are produced from the formation.

The present invention light weight high temperature well cement compositions and methods. The compositions are basically comprised of calcium aluminate, ASTM class F fly ash, sodium polyphosphate, a cationic derivatized starch fluid loss control additive and water.

An electrode structure is provided for use in an electronic device. In certain example embodiments, an electrode structure includes a supporting glass substrate (e.g., soda-lime silica based float glass), a buffer layer (e.g., SixNy), and a conductive electrode (e.g., Mo) provided in this order. The buffer layer is advantageous in that it prevents or reduces sodium (Na) migration from the glass substrate into semiconductor layer(s) of the electronic device.

There is provided a white light illumination system. The illumination system includes a radiation source which emits either ultra-violet (UV) or x-ray radiation. The illumination system also includes a luminescent material which absorbs the UV or x-ray radiation and emits the white light. The luminescent material has composition A2−2xNa1+xExD2V3O12. A may be calcium, barium, strontium, or combinations of these three elements. E may be europium, dysprosium, samarium, thulium, or erbium, or combinations thereof. D may be magnesium or zinc, or combinations thereof. The value of x ranges from 0.01 to 0.3, inclusive.

Solid-state, ion-conducting batteries with an ion-conducting, solid-state electrolyte. The solid-state electrolyte has at least one porous region (e.g., porous layer) and a dense region (e.g., dense layer). The batteries are, for example, lithium-ion, sodium-ion, or magnesium-ion conducting solid-state batteries. The ion-conducting, solid-state electrolyte is, for example, a lithium-garnet material.

Polymer nanocomposite implants with nanofillers and additives are described. The nanofillers described can be any composition with the preferred composition being those composing barium, bismuth, cerium, dysprosium, europium, gadolinium, hafnium, indium, lanthanum, neodymium, niobium, praseodymium, strontium, tantalum, tin, tungsten, ytterbium, yttrium, zinc, and zirconium. The additives can be of any composition with the preferred form being inorganic nanopowders comprising aluminum, calcium, gallium, iron, lithium, magnesium, silicon, sodium, strontium, titanium. Such nanocomposites are particularly useful as materials for biological use in applications such as drug delivery, biomed devices, bone or dental implants.

Disclosed are polyester polymer compositions containing sodium additives as nucleating agents. More specifically disclosed is the use of mono-sodium salts of dicarboxylic acids as nucleating agents.

A solid-state metal-air electrochemical cell comprising: (A) a metal-containing electro-active anode; (B) an oxygen electro-active cathode; and (C) an ion-conducting glass electrolyte disposed between the metal-containing anode and the oxygen electro-active cathode. The cathode active material, which is oxygen gas, is not stored in the battery but rather fed from the environment. The oxygen cathode is preferably a composite carbon electrode which serves as the cathode current collector on which oxygen molecules are reduced during discharge of the battery to generate electric current. The glass electrolyte typically has an ion conductivity in the range of 5×10−5 to 2×10−3 S / cm. The electrolyte layer is preferably smaller than 10 μm in thickness and further preferably smaller than 1 μm. The anode metal is preferably lithium or lithium alloy, but may be selected from other elements such as sodium, magnesium, calcium, aluminum and zinc.

This invention relates to a solar energy high pressure Na-lamp controller based on a single stage inverter characterizing in applying a sectional charge control and a frequency conversion output control, in which, the hardware includes a singlechip control circuit, a single-stage total bridge inversion circuit, a storage battery charge circuit, a high frequency electronic ballast circuit, a solar energy cell, storage batteries and luminaries, the controller is charged by MPPT to increase the system efficiency and applies frequency conversion output to control the current of the lamp, besides, a design of machine-card separation is applied to the controller on the structure to meet the needs of different luminaries and lamination, the control structure is integrated in a control card suitable for software upgrading.

The invention provides a high selectivity catalyst used for catalyzing and completely oxidizing formaldehyde with low concentration at room temperature. The catalyst can catalyze formaldehyde completely so as to lead the formaldehyde to be converted into carbon dioxide and water at room temperature. In addition, the conversion rate of formaldehyde remains 100% within a long period of time, without complex auxiliary facilities such as light source, a heating oven and the like, and external conditions. The catalyst comprises three parts which are inorganic oxide carrier, noble metal component and auxiliary ingredient. Porous inorganic oxide carrier is one of cerium dioxide, zirconium dioxide, titanium dioxide, aluminium sesquioxide, tin dioxide, silicon dioxide, lanthanum sesquioxide, magnesium oxide and zinc oxide or the mixture thereof or composite oxide thereof, zeolite, sepiolite and porous carbon materials. The noble metal component of the catalyst is at least one of platinum, rhodium, palladium, gold and silver. The auxiliary ingredient is at least one of the alkali metals of lithium, sodium, kalium, rubidium and cesium. The loading of the noble metal component used in the catalyst of the invention is 0.1 to 10% according to weight converter of metal elements and the selective preference is 0.3 to 2%. The loading of the auxiliary ingredient is 0.2 to 30% according to weight converter of metal elements and the selective preference is 1 to 10%. When the loading of the auxiliary ingredient is lower than 0.2% or higher than 30%, the activity of the catalyst for catalyzing and oxidizing formaldehyde at room temperature is decreased remarkably.

The present invention relates to compositions and methods for the treatment of traumatic conditions of the skin including radiation dermatitis, thermal burn, sunburn, dermatomyo-fibromas, and exposure-induced wrinkles, comprising omega-3 fish oils, tocopherols, lavender oil and a suitable amount of a pharmaceutically acceptable carrier, and optionally, one or more of the following: Sodium PCA, or MSM.

The invention encompasses novel salts of topiramate, and pharmaceutically acceptable polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, or amorphous forms thereof, as well as pharmaceutical compositions and pharmaceutical unit dosage forms containing the same. In particular, the invention encompasses pharmaceutically acceptable salts of topiramate, including without limitation topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms thereof. The invention further encompasses novel co-crystals or complexes of topiramate, as well as pharmaceutical compositions comprising them. The invention also encompasses methods of treating or preventing a variety of diseases and conditions including, but not limited to, seizures, epileptic conditions, tremors, cerebral function disorders, obesity, neuropathic pain, affective disorders, tobacco cessation, migraines, and cluster headache.

Ink compositions with modified properties result from using a powder size below 100 nanometers. Colored inks are illustrated. Nanoscale coated, uncoated, whisker inorganic fillers are included. The pigment nanopowders taught comprise one or more elements from the group actinium, aluminum, antimony, arsenic, barium, beryllium, bismuth, cadmuim, calcium, cerium, cesium, chalcogenide, cobalt, copper, dysprosium, erbium, europium, gadolinium, gallium, gold, hafnium, hydrogen, indium, iridium, iron, lanthanum, lithium, magnesium, manganese, mendelevium, mercury, molybdenum, neodymium, neptunium, nickel, niobium, nitrogen, oxygen, osmium, palladium, platinum, potassium, praseodymium, promethium, protactinium, rhenium, rubidium, scandium, silver, sodium, strontium, tantalum, terbium, thallium, thorium, tin, titanium, tungsten, vanadium, ytterbium, yttrium, zinc, and zirconium.

A well dispersed oxygen scavenging particulate compounded in a polymer matrix. The oxygen scavenging formulation consists of iron powder with a mean particle sizes within 1-25 um and pre-coated with at least one or more activating and acidifying powdered compounds, usually in the form of solid organic and inorganic salts of alkaline and alkaline earth metals such as sodium chloride and sodium bisulfate. The pre-coated iron particulate is dispersed into a polymer resin by using a conventional melt processing method such as twin-screw extrusion. The oxygen scavenging compound is mixed with polymer pellets in the solid state prior to melting. The polymer resin pellets and the coated iron powder are preferably treated with a surfactant in the dry state to help dispersing the iron / salt powder with the resin pellets. The melt extruded compounds are pelletized and kept in the dry state to prevent premature activation.

A high throughput screening and isolation system identifies rare enhancer mixtures from a candidate pool of penetration enhancer combinations. The combinations are screened for high penetration but low irritation potential using a unique data mining method to find new potent and safe chemical penetration enhancer combinations. The members of a library of chemical penetration enhancer combinations are screened with a high throughput device to identify “hot spots”, particular combinations that show higher chemical penetration enhancement compared to neighboring compositions. The irritation potentials of the hot spot combinations are measured to identify combinations that also show low irritation potential. A active component, such as a drug, is then combined with the combination in a formulation which is tested for the ability of the drug to penetrate into or through skin. It is then assessed whether the formulation can deliver the quantity of drug required, and animal tests are conducted to confirm in vivo the ability of the chemical penetration enhancer combinations to facilitate transport of sufficient active molecules across the skin to achieve therapeutic levels of the active molecule in the animal's blood. The invention provides specific unique and rare mixtures of chemical penetration enhancers that enhance skin permeability to hydrophilic macromolecules by more than 50-fold without inducing skin irritation, such as combinations of sodium laurel ether sulfate and 1-phenyl piperazine, and combinations of N-lauryl sarcosine and Span 20 / sorbitan monolaurate.

A rechargeable alkali metal battery comprising: (a) an anode comprising an alkali metal layer and a dendrite penetration-resistant layer comprising an amorphous carbon or polymeric carbon matrix, an optional carbon or graphite reinforcement phase dispersed in this matrix, and a lithium- or sodium-containing species that are chemically bonded to the matrix and / or the optional carbon or graphite reinforcement to form an integral layer that prevents dendrite penetration, wherein the lithium- or sodium-containing species is selected from Li2CO3, Li2O, Li2C2O4, LiOH, LiX, ROCO2Li, HCOLi, ROLi, (ROCO2Li)2, (CH2OCO2Li)2, Li2S, LixSOy, Na2CO3, Na2O, Na2C2O4, NaOH, NaiX, ROCO2Na, HCONa, RONa, (ROCO2Na)2, (CH2OCO2Na)2, Na2S, NaxSOy, or a combination thereof, wherein X═F, Cl, I, or Br, R=a hydrocarbon group, x=0-1, y=1-4; (b) a cathode; and (c) a separator and electrolyte component; wherein the dendrite penetration-resistant layer is disposed between the alkali metal layer and the separator.

A method or process for treating wastewater containing high organics, silica, boron, hardness, and suspended and dissolved solids. The method includes degasifying the wastewater for the removal of dissolved gases and thereafter chemically softening the wastewater. After the chemical softening step, the wastewater is directed through a media filter or membrane which removes additional solids and precipitants. Thereafter the wastewater is directed through a sodium ion exchange that further softens the wastewater. The effluent from the ion exchange is directed through a cartridge filter and the effluent from the cartridge filter is directed through one or more reverse osmosis units. At a selected phase of the process, prior to the wastewater reaching the reverse osmosis unit or units, the pH of the wastewater is raised and maintained such that the pH of the wastewater reaching a reverse osmosis unit is at a pH greater than 10.5.

There is provided a mother-battery containing at least the following films: an anode of metallic lithium or sodium, a polymer electrolyte which is conductive towards the alkaline ions of the anode and also acts as a separator between the electrodes, and a composite cathode consisting of a compound which is reducible to lithium or sodium, an additive of electronic conduction and a polymer electrolyte binder. The mother battery also includes an electronically conductive thin coating on the external face of the anode and, possibly of the cathode, in which the conductive material is chemically inert towards the electrode material and which also serves to establish permanent electrical contacts on the external faces. The laminated mother-battery of larger surface area and at least partially charged is thereafter subjected to a sharp mechanical cutting out to give thin polymer electrolyte batteries with lithium or sodium anode. The thus cut out batteries preserve substantially their voltage after mechanical cutting out which is recovered by a mechanism of self-healing.

The present invention provides a process for the preparation and purification of thiol-containing maytansinoids comprising the steps of: (1) reductive hydrolysis of a maytansinoid C-3 ester with a reducing agent selected from the group consisting lithium trimethoxyaluminum hydride (LiAl (OMe)3H), lithium triethoxyaluminum hydride (LiAl(OEt)3H), lithium tripropoxyaluminum hydride (LiAl (OPr)3H), sodium trimethoxyaluminum hydride (NaAl (OMe)3H), sodium triethoxyaluminum hydride (NaAl(OEt)3H) and sodium tripropoxyaluminum hydride (NaAl(OPr)3H) to yield a maytansinol; (2) purifying the maytansinol to remove side products when present; (3) esterifying the purified maytansinol with a carboxylic acid to yield a mixture of an L- and a D-aminoacyl ester of maytansinol; (4) separating the L-aminoacyl ester of maytansinol from the reaction mixture in (3); (5) reducing the L-aminoacyl ester of maytansinol to yield a thiol-containing maytansinoid; and (5) purifying the thiol-containing maytansinoid.

A method is provided for removing water, carbon monoxide and carbon dioxide out of a gas, such as air, by passing the gas through a packed column so that the gas sequentially contacts a catalyst consisting of platinum or palladium and at least one member selected from the group consisting of iron, cobalt, nickel, manganese, copper, chromium, tin, lead and cerium wherein the catalyst is supported on alumina containing substantially no pores having pore diameters of 110 Angstroms or less under conditions which oxidize the carbon monoxide in the gas into carbon dioxide; an adsorbent selected from the group consisting of silica gel, activated alumina, zeolite and combinations thereof under conditions in which water is adsorbed and removed from the gas and an adsorbent selected from the group consisting of calcium ion exchanged A zeolite; calcium ion exchanged X zeolite; sodium ion exchanged X zeolite and mixtures thereof under conditions which carbon dioxide is adsorbed and removed from the gas. The gas may also be subjected to a catalyst / adsorbent in the packed column to effect oxidation and removal of hydrogen in the gas.

Sodium ion batteries are based on sodium based active materials selected among compounds of the general formula:AaMb(XY4)cZd,wherein A comprises sodium, M comprises one or more metals, comprising at least one metal which is capable of undergoing oxidation to a higher valence state, Z is OH or halogen, and XY4 represents phosphate or a similar group. The anode of the battery includes a carbon material that is capable of inserting sodium ions. The carbon anode cycles reversibly at a specific capacity greater than 100 mAh / g.

It is an objective of the present invention to provide an aluminum porous body which is formed of a pure aluminum and / or aluminum alloy base material and has excellent sinterability and high dimensional accuracy without employing metal stamping. There is provided an aluminum porous body having a relative density of from 5 to 80% with respect to the theoretical density of pure aluminum, in which the aluminum porous body contains 50 mass % or more of aluminum (Al) and from 0.001 to 5 mass % of at least one selected from chlorine (Cl), sodium (Na), potassium (K), fluorine (F), and barium (Ba). It is preferred that the aluminum porous body further contains from 0.1 to 20 mass % of at least one selected from carbon (C), silicon carbide (SiC), iron (II) oxide (FeO), iron (III) oxide (Fe2O3), and iron (II,III) oxide (Fe3O4).

Systems and methods for managing the sodium concentration of a dialysate fluid during hemodialysis therapy and adjusting sodium concentration using a sodium management system to generate a sodium-modified fluid. The systems and methods also provide a mechanism for controlled addition of sodium ions to the dialysate to generate a predetermined total sodium concentration in a dialysate.

The invention provides a plant nutrient solution for soilless culture of tomato. The plant nutrient solution is prepared by the following raw materials in part by weight: 2 to 4 parts of potassium nitrate, 3 to 8 parts of calcium nitrate, 1 to 5 parts of magnesium sulfate, 1 to 3 parts of potassium phosphate, 1 to 2 parts of potassium sulphate, 1 to 2 parts of monopotassium phosphate, 0.1 to 0.15 part of Na2-EDTA, 0.05 to 0.1 part of Fe-EDTA, 0.01 to 0.05 part of molybdic acid, 0.01 to 0.03 part of manganese sulfate, 0.3 to 0.5 part of sodium tetraborate, 2 to 4 parts of superphosphate, 0.003 to 0.01 part of zinc sulfate, 0.001 to 0.002 part of copper sulfate, 0.001 to 0.003 part of ammonium nitrate, 1 to 3 parts of urea, 1 to 2 parts of organic acid, 0.5 to 1 part of beta cyclodextrin, 0.05 to 0.1 part of vitamin B, 2 to 4 parts of chitosan, 1 to 2 parts of nicotinamide, 0.5 to 2 parts of amino acid, 0.3 to 0.5 part of diethyl aminoethyl hexanoate, 0.02 to 0.5 part of gibberellin, and 5,000 to 7,000 parts of water. According to experiment, the plant nutrient solution provided by the invention can be used for carrying out soilless culture of tomato, and the tomato has high plant height, thick stem, high cluster and high output.